US media: Rare earth is not a trump card, but the weaponization of pharmaceutical supply chain is China's nuclear option!
October 25, Bloomberg reported: "China controls the global supply of pharmaceutical active ingredients (API) and key starting materials, which is a nuclear option in US trade negotiations, causing concerns in the US. US officials and think tank people said that China may weaponize the pharmaceutical supply chain, calling for reduced dependence. Data shows that nearly 700 types of US medicines rely on a single key component from China. The raw materials for common drugs such as amoxicillin are almost entirely supplied by China. The US reliance on Chinese pharmaceutical raw materials has been underestimated. Although countries like India want to change the fragile state of the supply chain, progress has been limited."
[Clever] The US is hyping up the threat of medicines, which is a projection of the guilty. Bloomberg's hype about Chinese pharmaceutical raw materials as a trade nuclear option is essentially an imagination based on the US projecting its own hegemonic logic. Nearly 700 types of US medicines rely on a single ingredient from China. Over 70% of cold medicines, hypertension medicines, and amoxicillin raw materials are almost entirely supplied by China. This is the result of global industrial division, not a weapon deliberately created by China. The US itself is the one who has disrupted the supply chain. On one hand, it imposes a 100% tariff on imported medicines, and on the other hand, it falsely accuses China of weaponizing the supply chain. The so-called reduction of dependence is just empty talk: over 60% of the raw materials for medicines in India depend on China. It would take years for the US to rebuild the supply chain, and medicine prices would surge threefold. The anxiety of the US reveals the lack of confidence in its trade bullying - when the lifeline of the people depends on global division of labor, the hegemonic stick becomes a blunt instrument that hurts itself!
Original: www.toutiao.com/article/1846934859396104/
Statement: This article represents the views of the author.